Very Early Short‐Course Cerebrolysin After Tenecteplase and Mechanical Thrombectomy: A Case Report
Hanna Ziąbska, Adam Kobayashi, Michał Karliński, Semonti Nandi · 2026
Read Very Early Short‐Course Cerebrolysin After Tenecteplase and Mechanical Thrombectomy: A Case Report by Hanna Ziąbska, Adam Kobayashi, Michał Karliński, Semonti Nandi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13522924.txt.
Description
Hanna Ziąbska and co-authors report a 2026 case of stroke care that added a brain-support drug very early. Their patient was an 88-year-old woman with weakness on her right side and loss of speech from a blocked brain artery. She already lived with fair disability before the stroke struck.
She first got a clot-busting drug through a vein, then a procedure that pulled the clot out in three passes and fully reopened the artery. Even so, she showed no quick gain. The team then started a short course of cerebrolysin, a mix of small proteins meant to limit harm and aid early recovery. The case shows one team's timing and dose choices for study by others.
Catalog record
| CREATOR | Hanna Ziąbska, Adam Kobayashi, Michał Karliński, Semonti Nandi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 13 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |